# Trial of EXenatide in Acute Ischaemic Stroke

> **NCT03287076** · PHASE2 · UNKNOWN · sponsor: **Neuroscience Trials Australia** · enrollment: 350 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Exenatide Injection

## Key facts

- **NCT ID:** NCT03287076
- **Lead sponsor:** Neuroscience Trials Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-23
- **Primary completion:** 2021-10-04
- **Final completion:** 2021-12-31
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2021-09-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03287076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03287076, "Trial of EXenatide in Acute Ischaemic Stroke". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03287076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*